Receptos, Inc. (RCPT) was a big mover last session with shares rising nearly 13% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company, as the stock is now up over 30% in the past one-month time frame.
This biopharmaceutical company has seen no estimate revision in the last 30 days. The Zacks Consensus Estimate has also remained unchanged over the same period. Yesterday’s rally is encouraging though, so make sure to keep a close watch on this firm in the near future.
Receptos currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.
However, better-ranked Med-Drug stocks include Jazz Pharmaceuticals plc (JAZZ), Zogenix, Inc. (ZGNX) and Sagent Pharmaceuticals, Inc. (SGNT). All these stocks carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment